Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

JAK inhibitors may reduce depression in people with alopecia areata.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Some dibenzo compounds might help treat cancer with fewer side effects.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Baricitinib is the most effective treatment for alopecia areata.

DRDE-07 shows promise for treating skin diseases due to its favorable properties.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.